Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to ...

This illustration image shows tablets of the opioid painkiller oxycodone. A novel non-opioid treatment for post-surgical pain, suzetrigine, is set to enter the market in 2025. Its uptake could be ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

Share on Pinterest Naltrexone (referred to as the “Ozempic of alcohol”) is a drug that can help reduce alcohol and opioid cravings for people living with substance misuse disorder. vitapix/Getty ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx works ...

The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a long ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Some of the most recently available data brings welcome news in the nationwide fight against the opioid epidemic. After many months of increasing overdose deaths in the wake of the Covid pandemic – a ...